Chihiro Udagawa
6PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Oct 21, 2022
Association between genetic variants and the risk of nivolumab-induced immune-related adverse events.Chihiro Udagawa, Mari Hara Nakano, Teruhiko Yoshida
|Feb 08, 2022
The association of four genetic variants with myelosuppression in gemcitabine-treated Japanese is not evident in gemcitabine/carboplatin-treated Swedes.Niclas Björn, Ingrid Jakobsen, Chihiro Udagawa
|Aug 12, 2020
Pharmacogenetics for severe adverse drug reactions induced by molecular-targeted therapy.Chihiro Udagawa, Hitoshi Zembutsu
|Oct 05, 2019
Whole genome sequencing to identify predictive markers for the risk of drug-induced interstitial lung disease.Chihiro Udagawa, Hidehito Horinouchi, Kouya Shiraishi
|Aug 31, 2018
A genome-wide association study identifies three novel genetic markers for response to tamoxifen: A prospective multicenter study.Hiroshi Onishi, Chihiro Udagawa, Michiaki Kubo
|Dec 17, 2017
Whole exome sequencing to identify genetic markers for trastuzumab-induced cardiotoxicity.Chihiro Udagawa, Hiromi Nakamura, Hiroshi Ohnishi
Pageof 1
